Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Precision NanoSystems announces partnership with Fujifilm for the development and GMP manufacturing of nanoparticle based therapeutics
Vancouver BC, March 23, 2020 Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license agreement with FUJIFILM Corporation to adopt PNI’s NanoAssemblr technology and complete suite of instruments for Fujifilm’ [...]
Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control
New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc. has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic. Asuragen’s proprietary Armor [...]
RareCyte announces the first blood-to-result PD-L1 Circulating Tumor Cell Assay
Seattle, WA, February 27, 2020 – RareCyte announces a new liquid biopsy blood test for programmed death-ligand 1 (PD-L1), enabling customers to evaluate PD-L1 expression on circulating tumor cells (CTCs) with industry leading sensitivity. PD-L1 is a biomarker that directs checkpoint inhibitor immuno [...]